U.S. Cancer Contrast Media Market Growth & Trends
The U.S. cancer contrast media market is anticipated to reach USD 1.53 billion by 2030 and is anticipated to expand at a CAGR of… Read More
On Target Laboratories, Inc. has obtained US Food and Drug Administration (FDA) approval of an expanded indication for the use of Cytalux (pafolacianine) for the detection of lung cancer dur… Read More
Diginota FDA aprueba CYTALUX un Medicamento Pionero para la Cirugía Del Cáncer De Ovario
On Target Laboratories: Anuncia la aprobación por la FDA de la inyección… Read More
MONDAY, Nov. 29, 2021 — Early detection of ovarian cancer helps boost a woman’s survival, and the U.S. Food and Drug Administration on Monday approved a new imaging drug that can… Read More